{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82", "Q1", 61458, "THE RABEN GROUP", 161678, "BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)", 2021, "first_quarter", "2021-04-19T19:29:05.473000-04:00", 10000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82/\", \"filing_uuid\": \"d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2021, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"10000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Robert Raben\", \"dt_posted\": \"2021-04-19T19:29:05.473000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1341 G street NW Flr 5\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20005\", \"registrant\": {\"id\": 61458, \"url\": \"https://lda.senate.gov/api/v1/registrants/61458/\", \"house_registrant_id\": 35394, \"name\": \"THE RABEN GROUP\", \"description\": \"National public affairs and strategic communications firm\", \"address_1\": \"525 9th Street NW\", \"address_2\": \"7th Floor\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ROBERT RABEN\", \"contact_telephone\": \"+1 202-466-8585\", \"dt_updated\": \"2026-01-27T13:56:41.710646-05:00\"}, \"client\": {\"id\": 161678, \"url\": \"https://lda.senate.gov/api/v1/clients/161678/\", \"client_id\": 1406, \"name\": \"BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)\", \"general_description\": \"Orgaization that promotes women's health\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2008-02-04\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\\n\\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 31195, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KATHARINE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HUFFMAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66979, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ABIGAIL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OMOJOLA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 68970, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DIEGO\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SANCHEZ\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Intern, Office of Representative Mike Coffman (CO-06)\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"ENV\", \"general_issue_code_display\": \"Environment/Superfund\", \"description\": \"Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\\n\\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 31195, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KATHARINE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HUFFMAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66979, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ABIGAIL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OMOJOLA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 68970, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DIEGO\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SANCHEZ\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Intern, Office of Representative Mike Coffman (CO-06)\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CHM\", \"general_issue_code_display\": \"Chemicals/Chemical Industry\", \"description\": \"Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\\n\\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 31195, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KATHARINE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HUFFMAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 68970, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DIEGO\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SANCHEZ\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Intern, Office of Representative Mike Coffman (CO-06)\", \"new\": false}, {\"lobbyist\": {\"id\": 66979, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ABIGAIL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OMOJOLA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CSP\", \"general_issue_code_display\": \"Consumer Issues/Safety/Products\", \"description\": \"Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\\n\\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 31195, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KATHARINE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HUFFMAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 68970, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DIEGO\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SANCHEZ\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Intern, Office of Representative Mike Coffman (CO-06)\", \"new\": false}, {\"lobbyist\": {\"id\": 66979, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ABIGAIL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OMOJOLA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82"], "units": {}, "query_ms": 8.706667926162481, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}